Code blue

9 Mar 2021 By John Foley

DocGo’s roaming medics, merging with a blank-check firm for $1.1 bln, are a creative addition to the U.S. healthcare system. The jargon-laden business is, however, in its early stages and unprofitable. The SPAC boom has blurred the line between good ideas and good investments.

This content is for Subscribers only

or
If you need assistance please email breakingviews.clientsupport@thomsonreuters.com
 

Email a friend

Please complete the form below.

Required fields *

*
*
*

(Separate multiple email addresses with commas)

We need you to verify your email address to continue. Please check your email/junk folder for our verification request.

Click here to resend the verification email.